Casualty Care Assessment of Russo-Ukraine War

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on September 18, 2025.

Award Information

This solicitation resulted in an award to for approximately $3,972,974 on September 18, 2025. Similar contracts are typically issued by DEPT OF DEFENSE under 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Award Number
HT942525PE041
Award Amount
$3,972,974
Award Date
September 18, 2025

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Set-aside for No Set Aside businesses
  • Work to be performed in FORT DETRICK, MD
  • Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Contract Details

Notice ID
HT942525PE041
Opportunity Type
Award Notice
Sub-Agency
DEFENSE HEALTH AGENCY (DHA)
Office
ARMY MED RES ACQ ACTIVITY
Posted Date
Thursday, September 18, 2025
Response Deadline
Not specified
PSC Code
AN11
Set-Aside
No Set Aside
Place of Performance
FORT DETRICK, MD, 21702
Status
Active

Description

The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the Defense Health Agency (DHA), Research & Engineering (R&E) Directorate, Combat Casualty Care (CCC) Portfolio awarded a contract to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc (6720A Rockledge Dr STE 100, Bethesda, Maryland 20817-1891) resulting from solicitation HT9425-25-R-E026 for Casualty Care Assessment of Russo-Ukraine War. This award will provide continued Research and Development to the Casualty Care Assessment of Russo-Ukraine War. The period of performance is 12-months.

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) with a set-aside for No Set Aside businesses in FORT DETRICK, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.